Form D · Other

Immusoft Corp

Seattle, WA · CIK 0001596274

Offering snapshot reported Jun 12, 2024 · SEC filing

Reported sold
$4.58M
Offering amount: $10M
Investors reported
25
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 28, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 12, 2024Initial$4,583,668No comparison25SEC filing
Mar 2, 2021Amendment$10,274,850$6,129,799vs Sep 23, 202032SEC filing
Sep 23, 2020Initial$4,145,051No comparison32SEC filing
Jan 25, 2019Amendment$20,170,006$16,556,977vs Jan 18, 201864SEC filing
Jan 18, 2018Initial$3,613,029No comparison32SEC filing
Nov 1, 2016Initial$2,739,999No comparison11SEC filing
Aug 18, 2015Initial$375,000No comparison3SEC filing
Aug 20, 2014Initial$2,374,458No comparison11SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-515744

Source: Form D, filed Jun 12, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark Ahn, Ph.D. Director
Sean Ainsworth Director, Executive
Richard Chin, M.D. Director
Cam Gallahger Director
Eric Garcia Executive
Eric Herbig Executive
Wendell King Director
Scott Mc Ivor Executive
Julia Moore Director
Matthew Scholz Director
Anthony Sun Director
Rich Vincent Executive

Issuer details

Industry: Other (See others in industry)

Address:
454 N. 34 Th Street
Seattle, WA, 98103